Lifecore Biomedical, Inc. provided revenue guidance for full year fiscal 2024. For the period, the company expects revenue to be in the range of $125 million to $130 million, depending on timing of customer shipments in fiscal fourth quarter.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.39 USD | +0.63% | -3.11% | +3.23% |
Apr. 19 | Lifecore Biomedical Gets Nasdaq Warning Over Delayed Quarterly Report | MT |
Apr. 01 | Lifecore Biomedical, Inc. Provides Revenue Guidance for Full Year Fiscal 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.23% | 195M | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- LFCR Stock
- News Lifecore Biomedical, Inc.
- Lifecore Biomedical, Inc. Provides Revenue Guidance for Full Year Fiscal 2024